Compounds > threonine

threonine and Pheochromocytoma, Extra-Adrenal

threonine has been researched along with Pheochromocytoma, Extra-Adrenal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cote, G; Grubbs, EG; Habra, MA; Hu, MI; Jasim, S; Jimenez, C; Rich, TA; Waguespack, SG; Ying, AK1
Bernardo, M; Chiang, J; Lonser, R; Lu, J; Martiniova, L; Pacak, K; Zhuang, Z1
Amosenko, FA; Brzhezovskiĭ, VZh; Gar'kavtseva, RF; Kalinin, VN; Kazubskaia, TP; Kozlova, VM; Liubchenko, LN; Shabanov, MA; Vanushko, VE1
Komminoth, P1
Miyasaka, J; Miyasaka, T; Saltiel, AR1

Other Studies

5 other study(ies) available for threonine and Pheochromocytoma, Extra-Adrenal

ArticleYear
Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:2

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Alanine; Carcinoma, Neuroendocrine; Female; Germ-Line Mutation; Humans; Methionine; Multiple Endocrine Neoplasia Type 2b; Phenylalanine; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Risk Factors; Threonine; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome

2011
Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.
    PloS one, 2011, Feb-14, Volume: 6, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mice; Neoplasm Metastasis; Pheochromocytoma; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Serine; Temozolomide; Threonine

2011
[Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Genetika, 2003, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Exons; Female; Humans; Male; Methionine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Mutation; Pedigree; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Russia; Threonine; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy

2003
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1995, Volume: 79

    Topics: Adrenal Gland Neoplasms; Awards and Prizes; Codon; Cysteine; Diagnosis, Differential; Drosophila Proteins; Genetic Carrier Screening; Humans; Hyperplasia; Methionine; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pathology; Pheochromocytoma; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Threonine; Thyroid Neoplasms

1995
Okadaic acid stimulates the activity of microtubule associated protein kinase in PC-12 pheochromocytoma cells.
    Biochemical and biophysical research communications, 1990, May-16, Volume: 168, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Epidermal Growth Factor; Ethers, Cyclic; Nerve Growth Factors; Okadaic Acid; Pheochromocytoma; Phosphorylation; Protein Kinases; Serine; Swine; Threonine; Tumor Cells, Cultured

1990